Skip to content

Clinical trials

Lung Neoplasms trials in Georgia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Country / region: Georgia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20102
20161
20191
20211
20232
20241
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting2
Recruiting2
Terminated2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peregrine Pharmaceuticals2
University Hospital Schleswig-Holstein2
BeiGene1
BioNTech SE1
CSL Behring1
Checkpoint Therapeutics, Inc.1
Formycon AG1
Prestige Biopharma Limited1
Regeneron Pharmaceuticals1
Samsung Bioepis Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms13
Carcinoma, Non-Small-Cell Lung9
Cachexia1
Carcinoma, Small Cell1
Fatigue1
Neoplasm Metastasis1
Small Cell Lung Carcinoma1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.